反応式
[F:1][C:2]1[CH:7]=[CH:6][C:5]([CH:8]([NH:12][C:13]2[CH:18]=[CH:17][CH:16]=[C:15]([F:19])[CH:14]=2)[C:9]([OH:11])=[O:10])=[CH:4][CH:3]=1.[N:20]12[CH2:27][CH2:26][CH:23]([CH2:24][CH2:25]1)[C@@H:22](O)[CH2:21]2.C1C=CC2N(O)N=NC=2C=1.C1CCC(N=C=NC2CCCCC2)CC1>C1COCC1>[F:1][C:2]1[CH:7]=[CH:6][C:5]([CH:8]([NH:12][C:13]2[CH:18]=[CH:17][CH:16]=[C:15]([F:19])[CH:14]=2)[C:9]([O:11][C@@H:22]2[CH:23]3[CH2:26][CH2:27][N:20]([CH2:25][CH2:24]3)[CH2:21]2)=[O:10])=[CH:4][CH:3]=1参加物
6
実験手順
A mixture of 2-(4-fluorophenyl)-2-(3-fluorophenylamino)acetic acid (I3) (510 mg, 1.94 mmol), (R)-quinuclidin-3-ol (246 mg, 1.94 mmol), HOBT (356 mg, 2.32 mmol), and DCC (480 mg, 2.32 mmol) in THF (10 ml) was stirred at room temperature overnight (UPLC-MS monitoring: complete conversion). The solvent was evaporated, the crude was dissolved in EtOAc, and the insoluble was removed by filtration. The clear solution was washed with 1N K2CO3 and then with brine. The organic layer was dried over Na2SO4, filtered and evaporated. The crude product was purified by silica gel chromatography (EtOAc/MeOH=8/2) to give (R)-quinuclidin-3-yl 2-(4-fluorophenyl)-2-(3-fluorophenylamino)acetate (360 mg, 50% yield, mixture of diastereomers).
後処理
- customThe solvent was evaporated
- dissolutionthe crude was dissolved in EtOAc
- customthe insoluble was removed by filtration
- washThe clear solution was washed with 1N K2CO3
- dry with materialThe organic layer was dried over Na2SO4
- filtrationfiltered
- customevaporated
- customThe crude product was purified by silica gel chromatography (EtOAc/MeOH=8/2)
出典と根拠
- ORDレコード
- ord-8bfe7afcb6cd4d8db3101347a360df3f
- 出典データセット
- uspto-grants-2013_10
- 特許番号
- US08563577B2
関連ノート
読み込み中…